Dapiprazole, Abilify (dapiprazole) is a small molecule pharmaceutical. Dapiprazole was first approved as Dapiprazole on 1990-12-31. It is used to treat mydriasis in the USA. It has been approved in Europe to treat bipolar disorder and schizophrenia. The pharmaceutical is active against alpha-1D adrenergic receptor.
|Trade Name||Abilify, Abilify Maintena|
|Indication||bipolar disorder, mydriasis, schizophrenia|
|Drug Class||Antiulcer agents (benzimidazole derivatives)|